|
|||||
A company in Maryland developing alternatives to human organ transplants is licensing a technology to help create 3-D printed lungs for transplantation with bioinks derived from tobacco plants. . . . → Read More: Licensing Deal for Bioinks in 3-D Printed Transplant Lungs 
Results from a clinical trial show external stimulation of a major nerve in the body helps relieve pan and fatigue in people with systemic lupus erythematosus, more commonly known as lupus. . . . → Read More: Nerve Stimulation Reduces Pain, Fatigue from Lupus 
A health care system in Boston is developing a mobile app to make it easier to share data from 250 home and wearable devices that collect medically related information. . . . → Read More: Health System Connects Mobile App to 250 Devices 
A university spin-off enterprise is receiving funds from National Institute of Mental Health to develop a simple, reliable electronic device to evaluate effects of neurological drugs on brain cells. . . . → Read More: NIH Supporting Electronic Neuro Drug Test Technology 
Drug maker AbbVie and biotechnology company Morphic Therapeutic are collaborating on new treatments for fibrosis based on Morphic’s technology blocking proteins that promote fibrosis. . . . → Read More: Harvard Spin-Off, AbbVie Partner on Fibrosis Treatments 
A new clinical trial is testing the drug semaglutide for people with type 2 diabetes against as many as 40 other diabetes treatments when used as a supplemental drug over 2 years. . . . → Read More: Diabetes Drug Assessed Long-Term Against All Other Treatments 
Researchers in Australia are conducting clinical trials of blood tests among cancer patients to help determine the course of their treatment, including the need for chemotherapy. . . . → Read More: Trials Evaluating Blood Tests to Guide Cancer Treatment 
A cloud-based open-source genomic sequencing program is underway to identify the source and nature of infectious diseases anywhere in the world. . . . → Read More: Infectious Disease Sequencing Service, Training Launched 
A synthetic antibody is shown in tests with lab mice to block the blood protein fibrin from causing inflammation and related damage to brain cells found in neurodegenerative diseases. . . . → Read More: Antibody Designed to Stop Inflammation Protein in Brain 
Early results from a clinical trial show a virtual rehabilitation program for people with total knee replacement surgery works as well as conventional rehab methods, but at a lower cost. . . . → Read More: Virtual Knee Replacement Rehab Shown Less Costly |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
